Senseonics Holdings, Inc. Schedules Fourth Quarter & Full Year 2020 Earnings Release & Conference Call for March 4, 2021 at 4...
Senseonics Holdings, Inc. (NYSE-American: SENS), a medical
technology company focused on the development and commercialization
of long-term, implantable continuous glucose monitoring (CGM)
systems for people with diabetes, today announced that it plans to
release its fourth quarter and full year 2020 financial results
after market close on Thursday, March 4, 2021.
Management will hold a conference call to review the company’s
fourth quarter and full year 2020 performance starting at 4:30 p.m.
(Eastern Time) on the same day. The conference call will be
concurrently webcast. The link to the webcast will be available on
Senseonics Holdings, Inc. website at www.senseonics.com by
navigating to “Investor Relations,” and then “Events &
Publications,” and will be archived there for future reference. To
listen to the conference call, please dial 1-888-317-6003
(US/Canada) or 1-412-317-6061 (International), passcode 3569931,
approximately ten to five minutes prior to start time.
Senseonics Holdings, Inc. is a medical technology company
focused on the design, development and commercialization of
transformational glucose monitoring products designed to help
people with diabetes confidently live their lives with ease.
Senseonics' CGM Systems, Eversense® and Eversense® XL, include a
small sensor inserted completely under the skin that communicates
with a smart transmitter worn over the sensor. The glucose data are
automatically sent every 5 minutes to a mobile app on the user's
version on businesswire.com: https://www.businesswire.com/news/home/20210219005102/en/
Senseonics Investor Contact Lynn Lewis or Philip Taylor
Investor Relations 415-937-5406 email@example.com